Found: 13
Select item for more details and to access through your institution.
Bimodal peaks of liver stiffness in a case of drug-induced liver injury.
- Published in:
- Hepatology Research, 2015, v. 45, n. 3, p. 343, doi. 10.1111/hepr.12341
- By:
- Publication type:
- Article
Icteric acute hepatitis E with no response of immunoglobulin M class anti-hepatitis E virus antibody.
- Published in:
- Hepatology Research, 2012, v. 42, n. 11, p. 1146, doi. 10.1111/j.1872-034X.2012.01023.x
- By:
- Publication type:
- Article
Changes in liver function parameters after percutaneous radiofrequency ablation therapy in patients with hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2010, v. 40, n. 5, p. 550, doi. 10.1111/j.1872-034X.2009.00613.x
- By:
- Publication type:
- Article
Evaluation of newly developed combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion: preliminary results.
- Published in:
- Hepatology Research, 2009, v. 39, n. 2, p. 117, doi. 10.1111/j.1872-034X.2008.00414.x
- By:
- Publication type:
- Article
Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2011, v. 16, n. 3, p. 221, doi. 10.1007/s10147-010-0151-9
- By:
- Publication type:
- Article
Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 13, p. 3302, doi. 10.1002/cncr.26648
- By:
- Publication type:
- Article
Effects of branched-chain amino acid-enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: A one-year prospective trial.
- Published in:
- Journal of Gastroenterology & Hepatology, 2010, v. 25, n. 9, p. 1550, doi. 10.1111/j.1440-1746.2010.06306.x
- By:
- Publication type:
- Article
Efficacy of Hepatic Arterial Infusion Chemotherapy Using 5-Fluorouracil and Systemic Pegylated Interferon α-2b for Advanced Intrahepatic Cholangiocarcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 11, p. 3638, doi. 10.1245/s10434-014-3766-7
- By:
- Publication type:
- Article
Efficacy of Hepatic Arterial Infusion Chemotherapy Using 5-Fluorouracil and Systemic Pegylated Interferon α-2b for Advanced Intrahepatic Cholangiocarcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 10, p. 3638, doi. 10.1245/s10434-014-3766-7
- By:
- Publication type:
- Article
Regulation of transforming growth factor is involved in the efficacy of combined 5-fluorouracil and interferon alpha-2b therapy of advanced hepatocellular carcinoma.
- Published in:
- Cell Death Discovery, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41420-018-0040-y
- By:
- Publication type:
- Article
The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver Function.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4873, doi. 10.3390/cancers14194873
- By:
- Publication type:
- Article
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 646, doi. 10.3390/cancers13040646
- By:
- Publication type:
- Article